Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration
Clinical trial NCT06495918 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06495918
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-27
- Primary completion
- 2027-01-08
- Enrollment
- 825
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.